The challenge of drug approval in rare cancers
Cancer
.
2021 Mar 15;127(6):837-839.
doi: 10.1002/cncr.33314.
Epub 2020 Nov 16.
Author
Bernd Kasper
1
Affiliation
1
Sarcoma Unit, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany.
PMID:
33197274
DOI:
10.1002/cncr.33314
No abstract available
Keywords:
TGCT; pexidartinib; rare cancer; registration; soft tissue sarcoma.
Publication types
Editorial
Comment
MeSH terms
Drug Approval*
Humans
Neoplasms* / drug therapy
Pyrroles
Substances
Pyrroles